Objective: The purpose of this study was to evaluate the influence of
tumor site on the therapy of an epxerimental murine kidney cancer mode
l, Ranca. Methods: Equal number of tumor cells were injected subcutane
ously, intraperitoneally, sub-renal capsule, and in travenously to ind
uce tumors. The animals were then assessed for growth of the primary t
umor, metastases and survival. Immunohistochemistry and flow cytometry
was performed to identify the phenotype of infiltrating lymphocytes.
Tumor bearing animals were treated with high dose interleukin-2 or who
le body radiation, and response of the primary tumors as well as the m
etastases was assessed. Results: Renca tumors grew well regardless of
the methods of induction. Spontaneous metastasis could be best induced
in the sub-renal capsule model. More consistent numbers of pulmonary
metastases were obtained by intravenous injection of the tumor cells.
Immunotherapy was able to reduce the size of the primary tumor as well
as the number of metastasis. Whole body radiation caused some reducti
on in the primary tumor but did not have a major effect in reducing me
tastasis. Conclusions: The Renca model is a suitable animal model to s
tudy the response to different therapeutic interventions. The site of
the tumor growth is not a significant variable in the response! to tre
atment.